California Public Employees Retirement System Neoleukin Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$147 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$9.23 - $13.12 $604,565 - $859,360	-65,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$11.26 - $15.78 $63,450 - $88,920	-5,635 Reduced 7.92%	65,500 $806,000
Q4 2020 Feb 02, 2021	SELL	$10.17 - $14.56 $46,120 - $66,029	-4,535 Reduced 5.99%	71,135 $1 Million
Q3 2020 Nov 05, 2020	BUY	$9.68 - $17.01 $73,780 - $129,650	7,622 Added 11.2%	75,670 $908,000
Q2 2020 Aug 12, 2020	BUY	$9.95 - $17.05 $347,732 - $595,863	34,948 Added 105.58%	68,048 $1.13 Million
Q1 2020 May 12, 2020	SELL	$6.12 - $13.64 $145,044 - $323,268	-23,700 Reduced 41.73%	33,100 $377,000
Q3 2019 Oct 31, 2019	BUY	$2.33 - $3.76 $132,344 - $213,568	56,800 New	56,800 $162,000

Others Institutions Holding NLTX

# of Institutions

Shares Held

199K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

199K
Shares

$0
0.18% of portfolio

View Full List

About Neoleukin Therapeutics, Inc.

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

More about NLTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account